Development of indole derived non-orthosteric inhibitors for Proto-oncogene serine/threonine-protein kinase PIM-1.
Saved in:
| Title: | Development of indole derived non-orthosteric inhibitors for Proto-oncogene serine/threonine-protein kinase PIM-1. |
|---|---|
| Authors: | Grau BW; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Tailor D; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Pandrala M; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Schultz KJ; Computational Biology Group, Pacific Northwest National Laboratory, Richland, WA, 99354, USA., Hsu EC; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA, 94304, USA., Dheeraj A; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Rolig AS; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Struntz NB; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Luong P; Department of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces, Am Mühlenberg 1, Potsdam-Golm, 14476, Germany; Bowdoin College, 6600 College Station, Brunswick, ME, 04011, USA., Stoyanova T; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA, 94304, USA., Sledge GW; Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, 94304, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA., Malhotra SV; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Electronic address: malhotsa@ohsu.edu. |
| Source: | European journal of medicinal chemistry [Eur J Med Chem] 2026 May 29; Vol. 316, pp. 118931. Date of Electronic Publication: 2026 May 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42217372 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of indole derived non-orthosteric inhibitors for Proto-oncogene serine/threonine-protein kinase PIM-1. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Grau+BW%22">Grau BW</searchLink>; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Tailor+D%22">Tailor D</searchLink>; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Pandrala+M%22">Pandrala M</searchLink>; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Schultz+KJ%22">Schultz KJ</searchLink>; Computational Biology Group, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+EC%22">Hsu EC</searchLink>; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.<br /><searchLink fieldCode="AU" term="%22Dheeraj+A%22">Dheeraj A</searchLink>; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Rolig+AS%22">Rolig AS</searchLink>; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Struntz+NB%22">Struntz NB</searchLink>; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Luong+P%22">Luong P</searchLink>; Department of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces, Am Mühlenberg 1, Potsdam-Golm, 14476, Germany; Bowdoin College, 6600 College Station, Brunswick, ME, 04011, USA.<br /><searchLink fieldCode="AU" term="%22Stoyanova+T%22">Stoyanova T</searchLink>; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.<br /><searchLink fieldCode="AU" term="%22Sledge+GW%22">Sledge GW</searchLink>; Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, 94304, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.<br /><searchLink fieldCode="AU" term="%22Malhotra+SV%22">Malhotra SV</searchLink>; Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA; Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Electronic address: malhotsa@ohsu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220420510%22">European journal of medicinal chemistry</searchLink> [Eur J Med Chem] 2026 May 29; Vol. 316, pp. 118931. <i>Date of Electronic Publication: </i>2026 May 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>0420510 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1768-3254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202235234%22">02235234 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42217372 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejmech.2026.118931 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 118931 Titles: – TitleFull: Development of indole derived non-orthosteric inhibitors for Proto-oncogene serine/threonine-protein kinase PIM-1. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Grau BW – PersonEntity: Name: NameFull: Tailor D – PersonEntity: Name: NameFull: Pandrala M – PersonEntity: Name: NameFull: Schultz KJ – PersonEntity: Name: NameFull: Hsu EC – PersonEntity: Name: NameFull: Dheeraj A – PersonEntity: Name: NameFull: Rolig AS – PersonEntity: Name: NameFull: Struntz NB – PersonEntity: Name: NameFull: Luong P – PersonEntity: Name: NameFull: Stoyanova T – PersonEntity: Name: NameFull: Sledge GW – PersonEntity: Name: NameFull: Malhotra SV IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 05 Text: 2026 May 29 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1768-3254 Numbering: – Type: volume Value: 316 Titles: – TitleFull: European journal of medicinal chemistry Type: main |
| ResultId | 1 |